Training

Register now

Location

Boston Medical Center- Crosstown
801 Massachusetts Avenue
2nd Floor, Room 2128
Boston, MA

Description

This eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.

Check-in for the course will be from 7:30am to 8:00am and the training will run from 8:00am to 4:30pm. DAY OF Contact: Colleen LaBelle - Colleen.Labelle@bmc.org - 617-797-6712 Breakfast and lunch will be provided. This is an in-person training. There will not be an option to attend via webinar.

Intended audience

Physicians (MD, DO), Nurse Practitioners, and Physician Assistants

Objectives

Upon completion of this 8 hour training, the participants will be able to:

• Have 8 hours of training required to apply for a waiver to prescribe buprenorphine to their patients with opioid dependence (addiction)
• identify and assess patients who are appropriate for treatment with buprenorphine
• have the specific knowledge concerning the use of buprenorphine to manage opioid dependence in the outpatient setting
• discuss the psychiatric and medical co-morbidities associated with opioid addiction

Sponsored by

Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS). 
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA.  The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health and the Bureau of Substance Abuse Services (DPH/BSAS). AAAP is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of physician participation in the learning process: Credit will only be awarded for completing all of the training. To be awarded a maximum of 8 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must complete all 8 hours of the course. Those completing the course will be able to complete the waiver application online.

Register now